A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells

Histone deacetylase (HDAC) inhibitors represent a novel class of anticancer agents, which can be used to inhibit cell proliferation and induce apoptosis in several types of cancer cells. In this study, we investigated the anticancer activity of MHY4381, a newly synthesized HDAC inhibitor, against hu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biomol Ther (Seoul)
Päätekijät: Richa, Sachan, Dey, Prasanta, Park, Chaeun, Yang, Jungho, Son, Ji Yeon, Park, Jae Hyeon, Lee, Su Hyun, Ahn, Mee-Young, Kim, In Su, Moon, Hyung Ryong, Kim, Hyung Sik
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Society of Applied Pharmacology 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059815/
https://ncbi.nlm.nih.gov/pubmed/31476841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2019.074
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia